The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, efficacy, and pharmacokinetics of XNW28012, a tissue factor antibody-drug conjugate (ADC) with topoisomerase 1 inhibitor (TOP1i) payload, in patients with advanced solid tumors: Results from a phase I/II study.
 
Miaoyan Wei
No Relationships to Disclose
 
Si Shi
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Jialin Li
No Relationships to Disclose
 
Nan Du
No Relationships to Disclose
 
Zhongtao Zhang
No Relationships to Disclose
 
Qiaofei Liu
No Relationships to Disclose
 
Haiping Jiang
No Relationships to Disclose
 
Jie Tang
No Relationships to Disclose
 
Fangling Ning
No Relationships to Disclose
 
Yongsheng Li
No Relationships to Disclose
 
Qiong Yang
No Relationships to Disclose
 
Honglin Hu
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Zuoxing Niu
No Relationships to Disclose
 
Meijie Le
Employment - Evopoint Biosciences
Leadership - Evopoint Biosciences
Stock and Other Ownership Interests - Evopoint Biosciences
 
Hongxia Zheng
Employment - Evopoint Biosciences
 
Jin Xu
No Relationships to Disclose
 
Xiaohua Wu
No Relationships to Disclose
 
Xianjun Yu
No Relationships to Disclose